|
STK11IP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.523600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.788400E-02 |
| Normal-vs-Stage2 |
1.672610E-01 |
| Normal-vs-Stage3 |
9.980800E-01 |
| Normal-vs-Stage4 |
7.545400E-01 |
| Stage1-vs-Stage2 |
4.186600E-01 |
| Stage1-vs-Stage3 |
2.872200E-02 |
| Stage1-vs-Stage4 |
1.212010E-01 |
| Stage2-vs-Stage3 |
1.667590E-01 |
| Stage2-vs-Stage4 |
2.062800E-01 |
| Stage3-vs-Stage4 |
7.507400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.876000E-01 |
| Normal-vs-AfricanAmerican |
1.384940E-04 |
| Normal-vs-Asian |
1.857950E-02 |
| Caucasian-vs-AfricanAmerican |
1.355560E-03 |
| Caucasian-vs-Asian |
2.377800E-01 |
| AfricanAmerican-vs-Asian |
9.265200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.405800E-01 |
| Normal-vs-Female |
4.922200E-03 |
| Male-vs-Female |
5.286200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.920400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.166300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.590000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.393800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.770400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.450000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.380020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.850200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.978400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.906820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.386600E-04 |
| Normal-vs-Grade 2 |
5.875700E-02 |
| Normal-vs-Grade 3 |
5.231600E-01 |
| Normal-vs-Grade 4 |
2.809000E-01 |
| Grade 1-vs-Grade 2 |
3.009700E-02 |
| Grade 1-vs-Grade 3 |
2.082000E-03 |
| Grade 1-vs-Grade 4 |
1.682810E-01 |
| Grade 2-vs-Grade 3 |
1.315250E-01 |
| Grade 2-vs-Grade 4 |
7.032600E-01 |
| Grade 3-vs-Grade 4 |
3.850400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.471000E-01 |
| Normal-vs-ccB subtype |
8.240300E-02 |
| ccA subtype-vs-ccB subtype |
6.772300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.645000E-01 |
| Normal-vs-N1 |
2.263000E-01 |
| N0-vs-N1 |
6.167600E-01 |
|
|
